Clinical trial GRAALL-2014 trial
Multicenter trial for the treatment of Acute Lymhoblastic Leukemia (ALL) in younger adults (18-59 years) (GRAALL-2014 trial)
| Cancers | |
|---|---|
| Organ | Acute leukemia |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2/3 |
| Academic trial | Oui |
| Sponsor | APHP |
| EudraCT Identifier | 2014-002146-44 |
| Inclusion criteria | blood and bone marrow exploration mandatory before steroids prephase /ALL B Phi negative, ALL B Phi positive, and ALL T eligible |
| Last update |